Clinical Trials

Drug Development Phase 3 Trials Drug Efficacy Randomized Controlled Trials Patient Care Phase 2 Trials Regulatory Approval Research Studies Regulatory Affairs Drug Safety

Single Psilocybin Dose Shows Rapid Antidepressant Effect in Phase 2 Trial

Early findings raise hope for faster care pending confirmation in larger, longer studies.

Novo Nordisk’s Wegovy Pill Shows Strong Results, Reinforcing Stock Rebound

Ajax Health Puts $60 Million Into UroMems to Advance Smart Urinary Sphincter

Odyssey Therapeutics Shares Rise 11% in Nasdaq Debut After $279 Million IPO

Gossamer Bio Faces Securities Class Action After PROSERA Failure, 80% Stock Plunge

Krystal Biotech Reports Strong Q1 on VYJUVEK, Readies Wider Launches

Inspire Medical Cuts 2026 Outlook as Coding Snags and Medicare AI Pilot Slow Procedures

Lilly to Acquire Ajax Therapeutics in Up to $2.3 Billion Blood Cancer Deal

Beta Bionics Lifts 2026 Sales Outlook as Q1 Revenue Jumps 57%

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

Spyre Drug Meets Midstage Target in Ulcerative Colitis, Stock Rallies

Gilead Expands Tempus Partnership for Enterprise Access to AI Oncology Platform

JW Pharmaceutical Licenses Korean Rights to Gan & Lee’s GLP-1 Drug in Deal Worth Up to $81 Million

MRI-Guided Robotic TMS With Therapy Delivers Strong PTSD Gains in Military Trial

Cyclerion to Merge With Korsana in Reverse Takeover Backed by $380 Million

Humacyte Reports 2025 Results, Cites Early Symvess Uptake and Near-Term Dialysis Readout

Waterdrop Posts 44% FY2025 Revenue Growth, Declares Dividend After Q4 Surge

Immutep Halts Phase III Lung Cancer Trial After Futility Call as Shares Crash

Early Trials of Gene Regulation Drug Cut Dravet Seizures by Up to 91%, NEJM Reports

Alpha-Synuclein Tied to Rapid Alzheimer’s Progression in Women, JAMA Study Finds